Neola Medical AB (OSTO:NEOLA) Net Margin %: 0.00% (As of Dec. 2025)


OSTO:NEOLA Neola Medical AB OSTO:NEOLA
29 GF Score
Price kr0.92
! 1 Warning Sign
View Full Analysis

What is Neola Medical AB Net Margin %?

Neola Medical AB OSTO:NEOLA +1.67% 29 Net Margin % is 0.00% as of Dec. 2025. GuruFocus rates OSTO:NEOLA with a GF Score™ of 29/100. The stock has 1 warning sign investors should review. Among 817 Medical Devices & Instruments companies, Neola Medical AB ranks worse than 122398.9% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Neola Medical AB's Net Income for the three months ended in Dec. 2025 was kr-2.66 Mil. Neola Medical AB's Revenue for the three months ended in Dec. 2025 was kr0.00 Mil. Therefore, Neola Medical AB's net margin for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for Neola Medical AB's Net Margin % or its related term are showing as below:


OSTO:NEOLA's Net Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.05
* Ranked among companies with meaningful Net Margin % only.

Neola Medical AB  (OSTO:NEOLA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Neola Medical AB Net Margin % Related Terms

Neola Medical AB Net Margin % Historical Data

* Premium members only.

The historical data trend for Neola Medical AB's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neola Medical AB Net Margin % Chart

Neola Medical AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial -1,064.48 0.00 0.00 0.00 0.00

Neola Medical AB Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OSTO:NEOLA vs ABT, SYK, MDT: Net Margin % Comparison

For the Medical Devices subindustry, Neola Medical AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neola Medical AB Net Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neola Medical AB's Net Margin % distribution charts can be found below:

* The bar in red indicates where Neola Medical AB's Net Margin % falls into.


OSTO:NEOLA
29GF Score
Neola Medical AB OSTO:NEOLA
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neola Medical AB Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Neola Medical AB's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-11.022/0
= %

Neola Medical AB's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-2.659/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Neola Medical AB (OSTO:NEOLA) has a Net Margin % of 0.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Neola Medical AB and its competitors. According to the industry distribution chart, Neola Medical AB ranks #999999 out of 817 companies in the Medical Devices & Instruments industry.
Is Neola Medical AB's Net Margin % too high?
Neola Medical AB's current Net Margin % is 0.00%. Based on the distribution chart, Neola Medical AB ranks #999999 out of 817 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Neola Medical AB has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Neola Medical AB's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Neola Medical AB ranks #999999 out of 817 companies for Net Margin %. This places Neola Medical AB in the lower half of its industry. The industry median Net Margin % is 2.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.05, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Neola Medical AB and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neola Medical AB's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neola Medical AB stock overvalued right now?
Neola Medical AB (OSTO:NEOLA) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Neola Medical AB's overall GF Score™ is 29/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Neola Medical AB (OSTO:NEOLA), the current Net Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neola Medical AB Business Description

Address Scheelevagen 27, Ideon Science Park, Gateway 9th fl oor, Lund, SWE, 223 63
Neola Medical AB is revolutionizing neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a technology that measures lung volume changes and oxygen gas concentration. NEOLA has the potential to provide care, fewer days in intensive care, and healthier lives for preterm born infants. The company is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to health care.
29GF Score

Get the complete analysis for OSTO:NEOLA

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.92
Price